Scottish Health Innovations Ltd (SHIL) works in partnership with NHS Scotland to identify, protect, develop and commercialise new innovations from healthcare professionals. Registered Number: SC 236303. Registered address: The Golden Jubliee National Hospital, Fourth Floor East, Agmemmon St, Clydebank, G81 4DY
Who we work with
Supporting health innovation across NHS, academia and industry
Who we work with
The health care industry has evolved significantly over the last decade driven by advances in technology and new approaches to patient care. This has accelerated the pace of innovation with many start-ups developing smart and innovative solutions to health issues, and established global companies driving innovative approaches to advancing healthcare solutions.
There are considerable mutual benefits for both the NHS and industry in working together to help identify and develop innovative products and services.
SHIL has a growing pipeline of disclosures from industry – largely concepts or early prototypes which require further development and clinical input to reach the point of commercialisation. In these situations, there are several possible ways in which SHIL can help to drive the project.
These options are explained in more detail below:
This approach allows SHIL to develop and commercialise the invention in the same way as an idea originating within a Health Board. If the IP associated to the idea has been developed to a more advanced stage, rather than assign IP rights to a Health Board, the company can retain the IP already created (background IP) and with SHIL’s assistance enter into a legal collaboration with a Board whereby any new (foreground IP) created under the collaboration is jointly owned. In return for assigning these rights, an agreed share of revenue from any successful commercialisation is received by the company.
SHIL works with Health Boards across Scotland and can support collaborative arrangements across NHS Scotland to help develop innovative ideas. Under this model, all rights to background IP would be retained by the company. Any new (foreground) IP developed as part of an NHS collaboration would be jointly owned by the parties, with a revenue share from any successful collaboration determined under a legally binding agreement.
In other cases, the company may already have a commercially-ready product which it is seeking to test in or sell to the NHS. In this instance an approach to the Health Innovation Assessment Portal (HIAP) would be recommended. This is an NHS Scotland Procurement-backed resource which provides companies with a route by which their product can be evaluated by expert assessors who will provide advice and guidance on how the product can be tested in an NHS setting or purchased by NHS Health Boards.
Want to know more?
- Get in touch with our Innovation team
- Review successfully commercialised products and spin outs
- Stay up to date on social media
- Access NHS Scotland Health Innovation Assessment Portal (HIAP)
- Access Scotland’s Health Research and Innovation Ecosystem Directory.